I was recently corresponding with an 88-year-old reader who had decided to hire a financial advisor. After years of ...

Shares of Milestone Pharmaceuticals climbed after the company said its first commercial product, Cardamyst nasal spray, was approved by the Food and Drug Administration to treat paroxysmal ...

Dow Jones Top Company Headlines at 9 AM ET: JPMorgan Steps Further Into Crypto With Tokenized Money Fund | Sanofi ... The new private fund will run on the Ethereum blockchain and be available to ...

Dow Jones Top Markets Headlines at 9 AM ET: Stock Futures Gain as Precious Metals Rally | What ... Stock futures edged higher ahead of a week of major economic data. The government shutdown put the ...

In October, Blake Werner, a 20-year-old sophomore at the University of Arkansas, saw a highly speculative trade he made in the market go his way. Werner had put up $26,500 on a call option on a ...

Gilead Sciences said its in-development HIV treatment met the primary endpoint of a recent late-stage clinical trial. The biopharmaceutical company said Monday that the treatment, a once-daily single ...

Shares in argenx fell after the pharmaceutical company said it would stop late-stage trials for an experimental drug to treat thyroid eye disease due to lack of efficacy. In European afternoon trading ...

The consumer-price index rose 2.2% from a year earlier in November, matching the pace the month before, Statistics Canada said Monday. That was slightly softer than the 2.3% economists expected, ...

Factory shipments dropped 1.0% from the month before to a seasonally adjusted 71.51 billion Canadian dollars, the equivalent of about $51.91 billion, Statistics Canada said Monday.

Grabbing a baby alligator with two hands: Akash Bhardwaj leaned into risk in 2025.

Consequently, the best trade for 2026, says BCA was to be short the Nasdaq 100 via the Invesco QQQ Trust Series I ETF QQQ and long iShares 20+ Year Treasury Bond ETF TLT, for a return of 52%.

The central bank voted 9-3 on Wednesday to cut its benchmark rate by a quarter point, to a range between 3.5% and 3.75%. Two favored no cut and one preferred a larger reduction. It was the first time ...